Yasuo Yoshioka is a Japanese radiation oncologist and brachytherapist. His main specialty is prostate cancer radiotherapy, including high- and low-dose-rate brachytherapy, intensity-modulated radiation therapy and stereotactic body radiation therapy. He is an expert in high-dose-rate (HDR) brachytherapy and reported the world’s first HDR monotherapy experience for prostate cancer. He implants gold markers/perirectal spacer by himself.
EDUCATION & LICENSE
1995 Osaka University Faculty of Medicine (Graduated), Medical Doctor (Japan)
2001 Université Claude Bernard Lyon 1
2002 Doctor of Philosophy, Osaka University Graduate School of Medicine
2006 Board Certified Radiation Oncologist, JASTRO and JRS
PROFESSIONAL EXPERIENCE
1995-1998 Resident, Osaka University Hospital and Osaka National Hospital
1998-2002 Graduate Student, Osaka University Graduate School of Medicine
2002-2004 Vice-chief physician, Division of Radiation Oncology, Shizuoka Cancer Center
2004-2008 Assistant Professor and Lecturer, Osaka University Graduate School of Medicine
2008-2017 Associate Professor, Osaka University Graduate School of Medicine
2017-2020 Division Director, High-precision Radiotherapy, Radiation Oncology Department,
Cancer Institute Hospital, Japanese Foundation for Cancer Research
2020-Present Department Director, Radiation Oncology Department, Cancer Institute Hospital,
Japanese Foundation for Cancer Research
PROFESSIONAL MEMBERSHIPS
ASTRO, ESTRO, JASTRO (councilor and official journal associate editor), Japan Radiological Society, Japan Society of Urologic Oncology (councilor), Japan Society of Gynecologic Oncology (councilor)
PUBLICATIONS (about 200 English articles and 1 book)
Yoshioka Y, et al. Nationwide, multicenter, retrospective study on high-dose-rate brachy-therapy as monotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2017;97:952-961.
Zaorsky NG, Yoshioka Y, et al. The evolution of brachytherapy for prostate cancer. Nat Rev Urol 2017;14:415-439.
Yoshioka Y, Itami J, Oguchi M, Nakano T (eds.). Brachytherapy: Techniques and Evidences. Springer Nature Singapore 2019.
讲座视频:0
论文摘要:1
19
0
0
日期 | 时间 | 会场 | Session | 角色 | 讲题 |
---|---|---|---|---|---|
2024-11-15 | 14:05-14:20 | 307会议室(三层) |
专题报告 1 |
讲者 | Role of radiotherapy to the primary or to the metastases in metastatic prostate cancer |